However, unlike liver cancer where TP53 mutations may be linked to population-specific risk factors51, we found no difference in the type or location of mutations nor in mutational signatures in Asian and Caucasian breast tumours, suggesting that the source of mutations may be similar in both populations. The gene discussed is TP53; the disease is breast neoplasm.